The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[[4-fluoro-3-[4-oxo-3,5-bis(4-pyridylmethylene)piperidine-1-carbonyl]phenyl]methyl]-2H-phthalazin-1-one ID: ALA4641362
PubChem CID: 156016263
Max Phase: Preclinical
Molecular Formula: C33H24FN5O3
Molecular Weight: 557.59
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C1/C(=C/c2ccncc2)CN(C(=O)c2cc(Cc3n[nH]c(=O)c4ccccc34)ccc2F)C/C1=C\c1ccncc1
Standard InChI: InChI=1S/C33H24FN5O3/c34-29-6-5-23(18-30-26-3-1-2-4-27(26)32(41)38-37-30)17-28(29)33(42)39-19-24(15-21-7-11-35-12-8-21)31(40)25(20-39)16-22-9-13-36-14-10-22/h1-17H,18-20H2,(H,38,41)/b24-15+,25-16+
Standard InChI Key: GPKLKSCYHFHTDH-FEZYOMQXSA-N
Molfile:
RDKit 2D
42 47 0 0 0 0 0 0 0 0999 V2000
2.2562 -12.8728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2550 -13.6923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9631 -14.1013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9613 -12.4639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6699 -12.8692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6687 -13.6944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3788 -14.1057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0947 -13.6964 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.0958 -12.8712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3812 -12.4553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3812 -11.6381 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3765 -14.9229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0831 -15.3335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0756 -16.1509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7813 -16.5614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4911 -16.1548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4908 -15.3333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7845 -14.9265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1982 -16.5644 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.1982 -14.9242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9062 -15.3323 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1976 -14.1070 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9020 -16.1463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6060 -16.5543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3158 -16.1487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3172 -15.3306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6087 -14.9180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0222 -16.5595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0260 -14.9239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0282 -14.1067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6034 -17.3715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8945 -17.7779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7354 -13.7030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7379 -12.8865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0308 -12.4752 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3196 -12.8863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3206 -13.7014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1897 -17.3660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4812 -17.7717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4783 -18.5898 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1897 -19.0004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8953 -18.5923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 2 0
7 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
17 20 1 0
20 21 1 0
20 22 2 0
21 23 1 0
21 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
25 28 2 0
26 29 2 0
29 30 1 0
24 31 2 0
31 32 1 0
30 33 2 0
33 34 1 0
34 35 2 0
35 36 1 0
36 37 2 0
37 30 1 0
32 38 2 0
38 39 1 0
39 40 2 0
40 41 1 0
41 42 2 0
42 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 557.59Molecular Weight (Monoisotopic): 557.1863AlogP: 4.64#Rotatable Bonds: 5Polar Surface Area: 108.91Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.96CX Basic pKa: 5.35CX LogP: 3.77CX LogD: 3.76Aromatic Rings: 5Heavy Atoms: 42QED Weighted: 0.32Np Likeness Score: -1.04
References 1. Lin S, Zhang L, Zhang X, Yu Z, Huang X, Xu J, Liu Y, Chen L, Wu L.. (2020) Synthesis of novel dual target inhibitors of PARP and HSP90 and their antitumor activities., 28 (9): [PMID:32222339 ] [10.1016/j.bmc.2020.115434 ] 2. Hu X, Zhang J, Zhang Y, Jiao F, Wang J, Chen H, Ouyang L, Wang Y.. (2022) Dual-target inhibitors of poly (ADP-ribose) polymerase-1 for cancer therapy: Advances, challenges, and opportunities., 230 [PMID:34998039 ] [10.1016/j.ejmech.2021.114094 ]